Gut microbiota modification by diosgenin mediates antiepileptic effects in a mouse model of epilepsy
This study suggests that diosgenin plays a role in modifying gut microbiota, contributing to the alleviation of intestinal inflammation and neuroinflammation, ultimately inhibiting epilepsy progression in a PTZ-induced mouse model. Diosgenin emerges as a potential therapeutic option for managing epilepsy and its associated comorbidities.
Source: Journal of Neurochemistry - Category: Neuroscience Authors: Xinyu Li,
Jing Li,
Jia Ji,
Saisai Li,
Xiaoyu Yao,
Hongbin Fan,
Ruiqin Yao Tags: ORIGINAL ARTICLE Source Type: research
More News: Alzheimer's | Bacteroides Infection | Brain | Epilepsy | Learning | Multiple Sclerosis | Neurology | Neuroscience | Parkinson's Disease | Stroke | Study | Transplants | Universities & Medical Training